Clinical Trials Logo

Urinary Tract Infection clinical trials

View clinical trials related to Urinary Tract Infection.

Filter by:

NCT ID: NCT03160807 Recruiting - Clinical trials for Urinary Tract Infection

Levofloxacin as an Empirical Therapy in Patients With Complicated Urinary Tract Infections

Levolet-KZ16
Start date: April 15, 2017
Phase: Phase 4
Study type: Interventional

Study is planned to evaluate safety and efficacy of Levolet in patients with complicated UTI

NCT ID: NCT03042273 Completed - Clinical trials for Urinary Tract Infection

High Strength Cranberry Supplementation for Prevention of Recurrent Urinary Tract Infection

Start date: May 15, 2017
Phase: Phase 2
Study type: Interventional

This clinical trial is a Phase 2, multicenter, placebo-controlled, double-blind, parallel-arm study to evaluate the efficacy and safety of High Strength Cranberry (500mg Pacran®) in preventing UTI (cystitis) in women with a history of recurrent UTI (rUTI).

NCT ID: NCT02882256 Completed - Clinical trials for Urinary Tract Infection

Video Discharge Instructions (VDI) as Adjuncts to Written Discharge Instructions in the Emergency Department

Start date: June 2016
Phase: N/A
Study type: Interventional

Patients seen in the ED with either a laceration, minor head injury, or urinary tract infection will be randomized to one of two groups. Both groups will receive the standard written discharge instructions; in addition, one group will watch video discharge instructions. Each patient will be asked to complete a short survey with questions related to the discharge instructions received in the ED, and will be called 5-7 days after the ED visit to ask questions about discharge instructions and the ED visit.

NCT ID: NCT02856633 Completed - Hypertension Clinical Trials

Preliminary Testing of the Vitaliti CVSM Wearable, Vitaliti Spirotoscope, and Vitaliti IVD Station

Start date: July 2016
Phase: N/A
Study type: Observational

The study objective is to satisfy the testing requirements for the Qualcomm Tricorder XPRIZE Competition. This requires an oversight model using the Vitaliti CVSM Wearable, Vitaliti Spirotoscope, and Vitaliti IVD Station to continuously monitor the patient's five core vital signs and to detect the health conditions required by the competition.

NCT ID: NCT02797613 Completed - Clinical trials for Urinary Tract Infection

Restricted Reporting for Positive Urine Cultures

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

Asymptomatic bacteriuria (AB) is a condition in which bacteria are detected in urine culture without urinary symptoms. The inappropriate use of antibiotic treatment for AB selects bacterial flora to express resistance mutations. Reducing inappropriate antibiotic use for AB is difficult, since the microbiology laboratory cannot distinguish patients with AB. The investigators study will use a restricted laboratory report requesting the physician to call the laboratory for culture results. The restricted report may reduce the rate of inappropriate treatment of AB.

NCT ID: NCT02786810 Completed - Clinical trials for Urinary Tract Infection

Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy

Start date: March 2016
Phase: Phase 2
Study type: Interventional

The study will be evaluating the efficacy and safety of a contrast drug in pediatric renal ultrasound.

NCT ID: NCT02785445 Completed - Diabetes Clinical Trials

Healthy.io Method Comparison & User Performance Study

Start date: October 2015
Phase: N/A
Study type: Interventional

The objectives of the Healthy.io Method Comparison and User Performance Study are: 1. To evaluate the performance of Dip.io Device in comparison to the ACON U500 Mission® U500 Urine Analyzer. 2. To evaluate the user performance of Dip.io Device under actual use conditions (home environment) based on a user questionnaire and rating scale.

NCT ID: NCT02751073 Completed - Clinical trials for Pelvic Organ Prolapse

Evaluation of the Relationship Between Vaginal and Lower Urinary Tract Microbiomes and Infection After Hysterectomy

Start date: February 2016
Phase:
Study type: Observational

The purpose of this study is to learn more about the microbes (bacteria) that live in the vagina and the bladder. The investigators are doing this research study to understand the relationship between microbes (the microbiome) and the occurrence of urinary tract infection following surgical removal of the uterus and pelvic organ prolapse repair. The investigators expect Lactobacillus and Gardnerella will be the dominant organisms for most women. Non-Lactobacillus dominant microbiome communities will be more common in women who ultimately develop postoperative urinary tract infection.

NCT ID: NCT02742636 Completed - Clinical trials for Urinary Tract Infection

When is the Best Moment to Remove the Urinary Catheter After Laparoscopic Hysterectomy?

MUCH
Start date: May 31, 2016
Phase: N/A
Study type: Interventional

Objective: The aim of this study is to evaluate if direct removal of the urine catheter after an laparoscopic hysterectomy (total laparoscopic hysterectomy and laparoscopic supracervical hysterectomy) is associated with similar (or better) outcomes compared to delayed catheter removal after surgery, which is the current treatment. In addition, we want to investigate patient's experience on this subject. Study design: Randomized Controlled trial, non-inferiority study. Study population: Women older than 18 years old, who are a laparoscopic hysterectomy for benign indication or low-grade malignancy. Intervention: - Group A (treatment group): the patients in this group will have their catheter directly removed in the OR after LH. - Group B (control group): the patients in the control group will have their catheter removed according to the regular protocol of the hospital (at least 6 hours in place).

NCT ID: NCT02698332 Completed - Clinical trials for Urinary Tract Infection

Effect of a Diagnostic Algorithm for Urinary Tract Infection in General Practice

Start date: March 2016
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the effect of diagnostic algorithm for urinary tract infection (UTI) on appropriate prescribing of antibiotics and use of diagnostics for patients with symptoms of urinary tract infection consulting their general practitioner. 70 general practices participating in an observational study regarding UTI are randomized to either receiving a diagnostic algorithm or not receiving anything additional. The study is observational on the patient level and interventional on the practice level.